Search for: "Freedom Pharmaceuticals, Inc" Results 101 - 120 of 152
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
22 Apr 2011, 2:49 pm by Lyle Denniston
The law was challenged in federal court by three data-mining companies, IMS Health Inc., Verispan LLC, and Source Healthcare Analytics, Inc., and by the trade group for drug manufacturers, the Pharmaceutical Research and Manufacturers of America. [read post]
6 Apr 2011, 12:14 pm by Eugene Volokh
(Eugene Volokh) The opinion, by an Illinois trial court, is at Morr-Fitz, Inc. v. [read post]
25 Mar 2011, 1:01 pm by Steve Hall
Nebraska announced in January that it had acquired 500 grams from Kayem Pharmaceutics of India, the minimum amount available for sale. [read post]
14 Mar 2011, 8:12 pm by Christa Culver
(forthcoming)Motion for leave to file out of time amicus brief of American Bankers AssociationPetitioner's reply Title: Mylan Inc. v. [read post]
8 Mar 2011, 7:21 am by Nabiha Syed
The Court also declined to review S&M Brands, Inc. v. [read post]
1 Mar 2011, 1:34 pm by John Elwood
Kuzinski (No. 10-459) and Novartis Pharmaceuticals Corp. v. [read post]
25 Feb 2011, 1:26 pm by Christa Culver
Chamber of CommerceAmicus brief of Pharmaceutical Research and Manufacturers of AmericaPetitioner's reply Title: Wine Country Gift Baskets.com v. [read post]
13 Jan 2011, 2:55 pm by Bexis
Medtronic, Inc., 623 F.3d 1200 (8th Cir. 2010) (we previously discussed Bryant here). [read post]
29 Nov 2010, 7:24 am by Anna Christensen
, Inc.Amicus brief for Teva Pharmaceuticals, et al.Amicus brief for Securities Industry and Financial Markets Association, et al.Amicus brief for IntelAmicus brief for Facebook Inc., et al.Amicus brief for Electronic Frontier Foundation, et al.Amicus brief for CTIA - The Wireless AssociationAmicus brief for Apple Inc.Amicus brief for Acushnet, et al.Amicus brief for Thirty-Six ProfessorsPetitioner's reply The following two cases were consolidated by the Court: Title: Arizona… [read post]
30 Sep 2010, 5:58 am by David G. Badertscher
The petitioners have asked the SEC to stay the Nov. 15 effective date of the rules pending conclusion of the litigation.Chief Justice to Hear Pfizer Cases After Selling Company's StockThe Associated PressChief Justice John Roberts has sold his shares of Pfizer Inc., a move that allows him to participate in two pending Supreme Court cases involving the pharmaceutical maker. [read post]